| 摘要 |
<p>The present invention relates to method for the cancer-related clinical validation of a target from disseminated cancer cells, to methods for the finctional validation of the targets, to merhods for treating cancer taking accounts of the status of at least one of said validated targets and to kits for target-related cancer treatment.</p> |
